|
In college, I worked summers in a research lab helping with gene therapy cancer research ... maybe half our time was spent doing grant proposals for breast cancer research, even though our lab's work would be much more useful for other forms of cancer (generally, less treatable/less easily targeted, albeit rarer, forms).
The corporatization of (specifically breast) cancer has created borderline monoliths, and they control the money, and thus help direct research. It's actually kind of awkward, having a corporate oligarchy for something like cancer research ... and while breast cancer obviously isn't completely solved, treatments are much more successful than many other cancers (even common ones).
It's not hyperbole to think that the actions of certain groups have pushed aside research attempts for other cancers. It's the cash reality.
|